During the past decade, Illinois CancerCare - Havana conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 117 clinical trials were completed, i.e. on average, 272.1% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 42 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare - Havana" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "Alliance for Clinical Trials in Oncology" with 39 trials sponsored, "Hoffmann-La Roche" with 17 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored and "Celgene" with 9 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare - Havana" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "NRG Oncology" with 6 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare - Havana" are "Breast Cancer" (18 trials), "Colorectal Cancer" (8 trials), "Lung Cancer" (8 trials), "Lymphoma" (7 trials) and "Leukemia" (5 trials). Many other conditions were trialed in "Illinois CancerCare - Havana" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare - Havana" are "Drug" (151 trials), "Other" (65 trials), "Biological" (49 trials), "Radiation" (14 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Carboplatin" (19 trials), "Bevacizumab" (18 trials), "Paclitaxel" (17 trials) and "placebo" (16 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare - Havana" are 145 trials for "All" genders, 25 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare - Havana". undefined are not yet recruiting, 16 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 86 completed trials in Illinois CancerCare - Havana, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare - Havana, 14 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Illinois CancerCare - Havana has several departments that took part in Clinical trials: "Illinois CancerCare-Dixon" - 125 trials, "Oncology Hematology Associates of Central Illinois, PC - Ottawa" - 108 trials, "Illinois CancerCare - Washington" - 106 trials, "Illinois CancerCare-Pekin" - 453 trials, "Illinois CancerCare-Peoria" - 389 trials, "Illinois CancerCare-Galesburg" - 365 trials, "Illinois CancerCare-Bloomington" - 356 trials, "Illinois CancerCare-Peru" - 354 trials, "Illinois CancerCare-Canton" - 351 trials, "Illinois CancerCare-Macomb" - 350 trials, "Illinois CancerCare-Eureka" - 348 trials, "Illinois CancerCare-Princeton" - 347 trials, "Illinois CancerCare-Kewanee Clinic" - 345 trials, "Illinois CancerCare-Carthage" - 343 trials, "Illinois CancerCare-Ottawa Clinic" - 324 trials